Proteomic analysis at the bedside: early detection of cancer.

Emanuel F. Petricoin; Lance A. Liotta

doi:10.1016/s1471-1931(02)00204-5

Proteomic analysis at the bedside: early detection of cancer.

Emanuel F. Petricoin^*
, Lance A. Liotta

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

37 Scopus citations

Abstract

Proteomic technologies promise to accelerate rapidly a new era in molecular medicine, especially in the detection and discovery of disease-related biomarkers. These technologies have no bigger impact than in the field of human cancer research. Beyond lifestyle-associated prevention strategies, early detection of cancer has the most profound impact on the ultimate course of the disease: the earlier the cancer is detected, the better the prognosis. Today, new proteomic technologies are being used to discover new diagnostic and prognostic biomarkers for the early detection and treatment of cancer that will have important implications at the bedside.

Original language	English
Pages (from-to)	S30-34
Journal	Trends in biotechnology
Volume	20
Issue number	12 Suppl
DOIs	https://doi.org/10.1016/s1471-1931(02)00204-5
State	Published - Dec 2002
Externally published	Yes

Access to Document

10.1016/s1471-1931(02)00204-5

Cite this

@article{5b632da803864b19baf98bcc67ed2d11,

title = "Proteomic analysis at the bedside: early detection of cancer.",

abstract = "Proteomic technologies promise to accelerate rapidly a new era in molecular medicine, especially in the detection and discovery of disease-related biomarkers. These technologies have no bigger impact than in the field of human cancer research. Beyond lifestyle-associated prevention strategies, early detection of cancer has the most profound impact on the ultimate course of the disease: the earlier the cancer is detected, the better the prognosis. Today, new proteomic technologies are being used to discover new diagnostic and prognostic biomarkers for the early detection and treatment of cancer that will have important implications at the bedside.",

author = "Petricoin, \{Emanuel F.\} and Liotta, \{Lance A.\}",

year = "2002",

month = dec,

doi = "10.1016/s1471-1931(02)00204-5",

language = "English",

volume = "20",

pages = "S30--34",

journal = "Trends in biotechnology",

issn = "0167-7799",

publisher = "Elsevier Ltd",

number = "12 Suppl",

}

TY - JOUR

T1 - Proteomic analysis at the bedside

T2 - early detection of cancer.

AU - Petricoin, Emanuel F.

AU - Liotta, Lance A.

PY - 2002/12

Y1 - 2002/12

N2 - Proteomic technologies promise to accelerate rapidly a new era in molecular medicine, especially in the detection and discovery of disease-related biomarkers. These technologies have no bigger impact than in the field of human cancer research. Beyond lifestyle-associated prevention strategies, early detection of cancer has the most profound impact on the ultimate course of the disease: the earlier the cancer is detected, the better the prognosis. Today, new proteomic technologies are being used to discover new diagnostic and prognostic biomarkers for the early detection and treatment of cancer that will have important implications at the bedside.

AB - Proteomic technologies promise to accelerate rapidly a new era in molecular medicine, especially in the detection and discovery of disease-related biomarkers. These technologies have no bigger impact than in the field of human cancer research. Beyond lifestyle-associated prevention strategies, early detection of cancer has the most profound impact on the ultimate course of the disease: the earlier the cancer is detected, the better the prognosis. Today, new proteomic technologies are being used to discover new diagnostic and prognostic biomarkers for the early detection and treatment of cancer that will have important implications at the bedside.

UR - https://www.scopus.com/pages/publications/0037945662

U2 - 10.1016/s1471-1931(02)00204-5

DO - 10.1016/s1471-1931(02)00204-5

M3 - Review article

C2 - 12570157

AN - SCOPUS:0037945662

SN - 0167-7799

VL - 20

SP - S30-34

JO - Trends in biotechnology

JF - Trends in biotechnology

IS - 12 Suppl

ER -

Proteomic analysis at the bedside: early detection of cancer.

Abstract

Access to Document

Fingerprint

Cite this